Nevertheless, the levels of IL-1β, IL-6, and TNF-α secreted by mature DC of MS patients are significantly higher as compared to those from healthy controls, even following treatment with 1,25(OH)2D3. The gene discussed is IL6; the disease is myeloid sarcoma.